An error occurred retrieving content to display, please try again.
Page not found (404)
Sorry - the page you requested could not be found.
Please choose a page from the navigation or try a website search above to find the information you need.
Toolkit
This study highlighted new strategies for monitoring disease activity and the immune competence of myeloma patients, demonstrating the need to protect patients against infections following diagnosis and also after anti-myeloma therapy.
1 Clinical Immunology Service, University of Birmingham, Birmingham, UK
2 Warwick Clinical Trials Unit, University of Warwick, Coventry, UK
3 King’s College Hospital NHS Foundation Trust, London, UK
4 Department of Medical Microbiology, St George’s, University of London, London, UK
5 Department of Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
6 Department of Haematology, University College London Cancer Institute, London, UK
7 Patient Advocacy, Myeloma UK, Edinburgh, UK
* Corresponding author Email: M.T.Drayson@bham.ac.uk
Funding: {{metadata.Funding}}
{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}
https://doi.org/{{metadata.DOI}}
Citation: {{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al.' : ''}} . {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})
Report Content
The full text of this issue is available as a PDF document from the Toolkit section on this page.
The full text of this issue is available as a PDF document from the Toolkit section on this page.
Responses to this report
No responses have been published.